PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancer

Francisco J. Esteva, Hua Guo, Siyuan Zhang, Cesar Santa-Maria, Steven Stone, Jerry S. Lanchbury, Aysegul A. Sahin, Gabriel N. Hortobagyi, Dihua Yu, PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer. American Journal of Pathology. ,vol. 177, pp. 1647- 1656 ,(2010) , 10.2353/AJPATH.2010.090885

E. Razis, M. Bobos, V. Kotoula, A. G. Eleftheraki, H. P. Kalofonos, K. Pavlakis, P. Papakostas, G. Aravantinos, G. Rigakos, I. Efstratiou, K. Petraki, D. Bafaloukos, I. Kostopoulos, D. Pectasides, K. T. Kalogeras, D. Skarlos, G. Fountzilas, Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer Breast Cancer Research and Treatment. ,vol. 128, pp. 447- 456 ,(2011) , 10.1007/S10549-011-1572-5

Marco Colleoni, Aron Goldhirsch, Neoadjuvant chemotherapy for breast cancer: any progress? The Lancet Oncology. ,vol. 15, pp. 131- 132 ,(2014) , 10.1016/S1470-2045(13)70584-9

Giuseppe Flauti, Francesco Ferrara, Daniele Marrelli, Franco Roviello, Giovanni Corso, Valeria Pascale, Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients. European Journal of Human Genetics. ,vol. 21, pp. 1383- 1388 ,(2013) , 10.1038/EJHG.2013.66

Libero Santarpia, Yuan Qi, Katherine Stemke-Hale, Bailiang Wang, Elliana J. Young, Daniel J. Booser, Frankie A. Holmes, Joyce O’Shaughnessy, Beth Hellerstedt, John Pippen, Tatiana Vidaurre, Henry Gomez, Vicente Valero, Gabriel N. Hortobagyi, W. Fraser Symmans, Giulia Bottai, Angelo Di Leo, Ana M. Gonzalez-Angulo, Lajos Pusztai, Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers Breast Cancer Research and Treatment. ,vol. 134, pp. 333- 343 ,(2012) , 10.1007/S10549-012-2035-3

Manfred Kaufmann, Gunter Von Minckwitz, Elefhterios P Mamounas, David Cameron, Lisa A Carey, Massimo Cristofanilli, Carsten Denkert, Wolfgang Eiermann, Michael Gnant, Jay R Harris, Thomas Karn, Cornelia Liedtke, Davide Mauri, Roman Rouzier, Eugen Ruckhaeberle, Vladimir Semiglazov, W Fraser Symmans, Andrew Tutt, Lajos Pusztai, None, Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Annals of Surgical Oncology. ,vol. 19, pp. 1508- 1516 ,(2012) , 10.1245/S10434-011-2108-2

Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai, Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, Carsten Denkert, PIK3CA Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer Journal of Clinical Oncology. ,vol. 32, pp. 3212- 3220 ,(2014) , 10.1200/JCO.2014.55.7876

Hua Yuan, Jiuan Chen, Yiqiang Liu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie, Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer Clinical Cancer Research. ,vol. 21, pp. 4365- 4372 ,(2015) , 10.1158/1078-0432.CCR-14-3354

Aron Goldhirsch, Eric P Winer, AS Coates, RD Gelber, Martine Piccart-Gebhart, B Thürlimann, H-J Senn, Panel Members, Kathy S Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold Burstein, Fatima Cardoso, Monica Castiglione-Gertsch, Alan S Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E Davidson, Angelo Di Leo, Bent Ejlertsen, John F Forbes, Richard D Gelber, Michael Gnant, Aron Goldhirsch, Pamela Goodwin, Paul E Goss, Jay R Harris, Daniel F Hayes, Clifford A Hudis, James N Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moise Namer, C Kent Osborne, Ann H Partridge, Frédérique Penault-Llorca, Charles M Perou, Martine J Piccart-Gebhart, Kathleen I Pritchard, Emiel JT Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Zhi-Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P Winer, William C Wood, None, Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Annals of Oncology. ,vol. 24, pp. 2206- 2223 ,(2013) , 10.1093/ANNONC/MDT303

Yardena Samuels, Zhenghe Wang, Alberto Bardelli, Natalie Silliman, Janine Ptak, Steve Szabo, Hai Yan, Adi Gazdar, Steven M Powell, Gregory J Riggins, James KV Willson, Sanford Markowitz, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu, High Frequency of Mutations of the PIK3CA Gene in Human Cancers Science. ,vol. 304, pp. 554- 554 ,(2004) , 10.1126/SCIENCE.1096502